Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative negative emotions and early cognitive impairment after laparoscopic bariatric surgery
ChiCTR2600117683Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in post-operative cognitive decline (POCD), postoperative pain, anxiety disorder and 2 more (3 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: Pain score (Visual Analogue Scale), Hospital Anxiety and Depression Scale score and 7 more. Started Jan 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
post-operative cognitive decline (POCD)postoperative painanxiety disorderpostoperative depressionpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600117683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117683.